NCNA

NuCana
NCNA

Overview Fund Trends Analyst Outlook Journalist POV
4.01 USD
+0.30
8.09%
At close Updated Oct 31, 4:00 PM EDT
Pre-market
After hours
4.04
+0.03
0.75%
1 day
8.09%
5 days
-4.52%
1 month
-13.58%
3 months
-53.26%
6 months
-96.6%
Year to date
-98.38%
1 year
-98.76%
5 years
-99.98%
10 years
-100%
 

About: NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

Employees: 22

Healthcare Biotechnology
0
Funds holding %
of 7,505 funds
Explore Fund Trends
–
Analysts bullish %
See Analyst Outlook
–
Positive news %
Check Journalist POV
Price charts implemented using Lightweight Charts™